Ventyx Biosciences advances a broad pipeline of potent and selective small-molecule drug candidates to treat inflammatory diseases and autoimmune disorders.
For more details on financing and valuation for Ventyx Biosciences, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
VTYX
34.55 as of 3/29/23
To read this article and more news on Ventyx Biosciences, register or login.
